2003
DOI: 10.1203/01.pdr.0000057205.64451.b7
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal Skin in Mice and Humans Expresses Increased Levels of Antimicrobial Peptides: Innate Immunity During Development of the Adaptive Response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
100
0
5

Year Published

2004
2004
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 133 publications
(106 citation statements)
references
References 34 publications
1
100
0
5
Order By: Relevance
“…Furthermore, expression of the cathelicidin gene ( CRAMP -shown to be 10-100 fold greater in neonatal mice than in the adult), is thought to provide an important compensatory neonatal innate immune defence mechanism [15] .…”
Section: B-defensinsmentioning
confidence: 99%
“…Furthermore, expression of the cathelicidin gene ( CRAMP -shown to be 10-100 fold greater in neonatal mice than in the adult), is thought to provide an important compensatory neonatal innate immune defence mechanism [15] .…”
Section: B-defensinsmentioning
confidence: 99%
“…Over 26 human beta-defensins have been identified [11,12]. Expression of some beta-defensins, such as human beta-defensin-1 (HBD-1), is constitutive, whereas expression of other beta-defensins, such as HBD-2, 3, and 4, [4,8,13], mouse beta-defensin-2 [14], tracheal antimicrobial peptide (TAP) and lingual antimicrobial peptide (LAP) of cattle, is inducible [15 -18]. Induction often occurs secondary to activation of Toll-like receptor 4 (TLR 4) and NF-kappa B signaling [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…This was not unexpected and is most likely explained by the fact that in the host, antimicrobial mechanisms are thought to act synergistically to kill bacteria. Synergistic bactericidal activity has been demonstrated experimentally in vitro between AMPs, and between AMPs and other innate immunity proteins such as lysozyme, which is one of the most abundant antimicrobial proteins in the airspaces of the lung (53)(54)(55)(56). Future studies will characterize the sensitivity of the GBS ponA mutant to other host bactericidal factors that are present in the airway.…”
Section: Discussionmentioning
confidence: 97%